Market Place
Sourcing Support
Mylan Pharms Generic Aripiprazole Receives Tentative Approval in US
27 Jun 2024 //
FDA
Otsuka, Lundbeck start ad push for long-acting bipolar drug
05 Jun 2024 //
FIERCE PHARMA
Enforcement Report - Week of May 1, 2024
01 May 2024 //
FDA
Otsuka and Lundbeck’s schizophrenia treatment gains EC approval
28 Mar 2024 //
PHARMACEUTICAL TECHNOLOGY
Sunshine Lake Pharma`s Generic Aripiprazole Receives Approval in the U.S.
02 Oct 2023 //
FDA
FDA Greenlights First Bi-Monthly Inje for Schizophrenia, Bipolar 1 Disorder
02 May 2023 //
BIOSPACE
FDA Approves Otsuka and Lundbeck’s ABILIFY ASIMTUFII® (aripiprazole)
27 Apr 2023 //
BUSINESSWIRE
Enforcement Report - Week of April 26, 2023
26 Apr 2023 //
FDA
Enforcement Report - Week of April 12, 2023
12 Apr 2023 //
FDA
Otsuka and Lundbeck Published Study Results Showing Aripiprazole 2-Month
04 Apr 2023 //
BUSINESSWIRE
Enforcement Report - Week of March 8, 2023
08 Mar 2023 //
FDA
Rubicon`s Generic Aripiprazole Receives Approval in the U.S.
27 Oct 2022 //
FDA
Glasshouse`s Generic Aripiprazole Receives Approval in the U.S.
25 Oct 2022 //
FDA
FDA accepts Otsuka filing for long-acting schizophrenia drug
14 Sep 2022 //
FIERCEPHARMA
Enforcement Report - Week of July 27, 2022
27 Jul 2022 //
FDA
EMA Commences Review of Aripiprazole 2-Month Long-Acting Injectable
17 Jun 2022 //
PRESS RELEASE
Unichem`s Generic Aripiprazole gets Approval in the U.S.
01 Dec 2021 //
FDA
Backed with $500M, a startup aims to rethink psychiatric drug development
07 Oct 2021 //
STATNEWS
Unichem Lab receives USFDA approval for Aripiprazole Tablets; Stock soars 3%
01 Jul 2021 //
INDIAINFOLINE
Unichem Labs` Generic Aripiprazole Receives Approval in the U.S
29 Jun 2021 //
FDA
Enforcement Report - Week of December 9, 2020
09 Dec 2020 //
FDA
Otsuka Applies for the Additional Indication in Japan for ABILIFY MAINTENA
25 Sep 2020 //
PRESS RELEASE
Otsuka’s 1st Half Pharma Sales Rise 7.6% as 4 Global Brands Fare Well
11 Aug 2020 //
JIHO
Enforcement Report - Week of July 1, 2020
01 Jul 2020 //
FDA
Vistapharm`s Generic Aripiprazole Receives Approval in US
27 Dec 2019 //
FDA
Lundbeck’s key products shine in Q2 but problems remain
14 Aug 2019 //
PMLIVE
Accord-UK Ltd Recalls Aripiprazole 1mg/ml oral solution (EL (19)A/20)
30 Jul 2019 //
GOVUK
Biohaven, sporting new data, moves closer to CGRP finish line—and maybe M&A
11 Jul 2019 //
FIERCE PHARMA
Aurobindo Pharma`s Generic Aripiprazole Receives Approval in US
29 Jan 2019 //
FDA
When medicine makes you sick: How tainted drugs can elude FDA inspections
11 Jan 2019 //
USA TODAY
Zydus Cadila gets USFDA nod for antipsychotic drug
09 Jan 2019 //
ECONOMIC TIMES
Pharmtak`s Generic Aripiprazole Receives Tentative Approval in US
28 Dec 2018 //
FDA
Pharmtak`s Generic Aripiprazole Receives Tentative Approval in US
27 Dec 2018 //
FDA
Enforcement Report - Week of October 10, 2018
10 Oct 2018 //
FDA
A summer of manufacturing disasters for Chinese pharma
24 Sep 2018 //
Mylan Pharms` Generic Aripiprazole Receives Approval in US
22 Sep 2018 //
FDA
Fosun Pharma ‘massively’ fakes API production data - whistleblower
01 Sep 2018 //
FIERCE PHARMA
Zydus Pharms USA`s Generic Aripiprazole Receives Approval in US
31 Aug 2018 //
FDA
At $1,650 per month, the first digital pill will roll out to Medicaid patients
29 Aug 2018 //
STAT NEWS
Woman Sues Abilify Marketers Over Hefty Gambling Losses
02 Aug 2018 //
BIOSPACE
FDA Approves ARISTADA INITIO for the Initiation of ARISTADA for Schizophrenia
02 Jul 2018 //
PRESS RELEASE
Sciegen Pharm’s Generic Aripiprazole Receives Approval In US
21 Apr 2018 //
FDA
Japanese firm’s patent on anti-psychotic drug rejected
13 Mar 2018 //
TIMES OF INDIA
Enforcement Report - Week of February 21, 2018
21 Feb 2018 //
FDA
Enforcement Report - Week of February 14, 2018
14 Feb 2018 //
FDA
Prinston’s Generic Aripiprazole Receives Approval In US
07 Dec 2017 //
FDA
First digital medicine approved in the US
15 Nov 2017 //
PMLIVE
ABILIFY MAINTENA® aripiprazole for Extended-Release Inj Approved by U.S. FDA
28 Jul 2017 //
BUSINESSWIRE
Orchid Hlthcare’S Generic Aripiprazole Receives Approval In US
24 May 2017 //
FDA
Otsuka, Proteus resubmit NDA to US FDA for digital medicine, Abilify
24 May 2017 //
PHARMABIZ
Otsuka refiles `digital` medicine for mental illness
24 May 2017 //
PMLIVE
Enforcement Report - Week of May 10, 2017
10 May 2017 //
FDA
Abilify® (Aripiprazole): Otsuka Pharmaceutical V. Zydus & Cadila Healthcare Ltd
21 Apr 2017 //
PATENT LITIGATION
Drugmakers `hijacked` the FDA`s orphan system to score premium pricing
17 Jan 2017 //
FIERCE PHARMA
Stason`s Generic Aripiprazole Receives Approval In US
09 Jan 2017 //
FDA
Bristol-Myers to pay $19.5 million in Abilify off-label marketing settlement
14 Dec 2016 //
FIERCE PHARMA
Bristol-Myers Squibb to Pay $19.5 Million to Settle Off-Label Promotion Case
09 Dec 2016 //
REUTERS
Accord`s Generic Aripiprazole Recevies Approval In US
07 Dec 2016 //
FDA
USFDA accepts review of supplemental NDA to expand labeling of Abilify Maintena
30 Nov 2016 //
GLOBENEWSWIRE
Harvoni, Lantus top Medicare, Medicaid drug spend as U.S. total hits $457B
15 Nov 2016 //
FIERCE PHARMA
